Please assess the completion status of the following clinical trial:

Trial Title: Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion criteria:~1. Healthy male and female subjects~Exclusion criteria:~1. Any relevant deviation from healthy conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 Empagliflozin/Metformin (T) (Type: EXPERIMENTAL): fixed-dose-combination tablet, oral with 240 ml water under fasted conditions
- 2 Empagliflozin/Metformin (T) (Type: EXPERIMENTAL): fixed-dose-combination tablet, oral with 240 ml water under fed conditions
- 3 Empagliflozin + Metformin (R) (Type: EXPERIMENTAL): tablets, oral with 240 ml water under fasted conditions
- 4 Empagliflozin + Metformin (R) (Type: EXPERIMENTAL): tablets, oral with 240 ml water under fed conditions
- 5 Empagliflozin/Metformin (T) (Type: EXPERIMENTAL): fixed-dose-combination tablet, oral with 240 ml water under fed conditions
- 6 Empagliflozin + Metformin (R) (Type: EXPERIMENTAL): tablets, oral with 240 ml water under fed conditions

Based on this trial design, predict the completion outcome and termination type (if applicable).